Compare FCCO & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCCO | IPSC |
|---|---|---|
| Founded | 1994 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 321.1M | 362.5M |
| IPO Year | 2012 | 2021 |
| Metric | FCCO | IPSC |
|---|---|---|
| Price | $33.94 | $2.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.25 |
| AVG Volume (30 Days) | 43.9K | ★ 564.1K |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | 36.46 | ★ 91.30 |
| EPS | ★ 1.39 | N/A |
| Revenue | $922,000.00 | ★ $109,164,000.00 |
| Revenue This Year | $30.67 | N/A |
| Revenue Next Year | $5.87 | N/A |
| P/E Ratio | $24.32 | ★ N/A |
| Revenue Growth | N/A | ★ 1556.76 |
| 52 Week Low | $25.92 | $0.44 |
| 52 Week High | $35.74 | $2.97 |
| Indicator | FCCO | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 49.30 |
| Support Level | $32.35 | $1.88 |
| Resistance Level | $35.74 | $2.39 |
| Average True Range (ATR) | 0.96 | 0.10 |
| MACD | -0.10 | 0.02 |
| Stochastic Oscillator | 54.97 | 71.74 |
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.